Revolutionary biotech using patented Zinc Finger platform.
Strong cash position.
Recent additions to the BOD have experience and connections to negotiate new partnerships.
| Price | 4.32 |
| Price Change Today | -$0.46 (-9.62%) |
| P&P rating | ![]() |
| Zacks Rank | 3 - HOLD |
| Open Price | $4.83 |
| Previous Close | $4.78 |
| Daily Range | $4.31 - $4.83 |
| 52-Week Range | $2.36 - $9.15 |
| Volume | 482,665 |
| Sangamo BioSciences, Inc. is a leader in the development of novel transcription factors for the regulation of gene expression. Transcription factors are proteins that turn genes on or off by recognizing specific DNA sequences. The Universal Gene Recognition technology platform enables the engineering of a class of transcription factors known as zinc finger DNA binding proteins. | |





Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 5 | Comment
Strong cash position.
Recent additions to the BOD have experience and connections to negotiate new partnerships.
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment